PharmaLive talked to Conran Design Group Managing Director Christina Falzano about her experiences working with tech companies’ expansion into the health, wellness and pharma spaces in driving changes in the healthcare industry – especially in how they reposition post-COVID.

Join this webinar for a compelling presentation from TLD Group Advisor and Senior Consultant Dr. Kent Bottles who discuss American Healthcare in 2021: What Should Providers, Patients, & Citizens Expect?

Huntsworth, an international healthcare and communications group, announced an agreement to acquire Nucleus Global, one of the world’s largest medical specialist communications groups.

Ed Hudson, managing director at Create Health, discusses the increasing importance of brand in pharma – especially in light of increased competition.

Full-service healthcare communications marketing agency MicroMass Communications launched the podcast series Intersect, which tells stories of behavioral science in action.

Denials management is an ongoing issue that is always surrounded by a buzz of industry noise. This webinar aims to cut through the noise with practical tips for defining, classifying, and tracking denials from someone who has spent years doing that work herself.

Fernando Fernandez, Managing Director of FCB Health Network’s BX – Brand Experience Design Group, talked to Med Ad News about how COVID-19 has changed the way people interact with brands, how branding innovations such as audio and motion identities are making their way to pharma, and other topics.

Health care communications and marketing leader Gulden Mesara will join City of Hope, a world-renowned independent cancer and diabetes research and treatment center, as senior vice president and chief communications and marketing officer.

The HBA’s Tomorrow’s Executives affinity group, with the support of Bristol Myers Squibb, offers this four-part series to connect you with future and current leaders of top biopharmaceutical companies. These webinars (scheduled from September 9 through October 16, 2020) will highlight the achievements of the next generation across the industry and underscore the importance of their contributions to their organization, and beyond. Join us as we explore: social intrapreneurship, diversity in clinical trials, COVID-19 responses, and how young professionals are impacting the future of work.

President Donald Trump will sign three executive orders on lowering prescription drug prices, White House Chief of Staff Mark Meadows said.